Primary sclerosing cholangitis: liver transplantation or biliary surgery

Area of Science:

• Hepatology
• Transplant Surgery
• Gastroenterology

Background:

• Limited data exists on liver transplantation for primary sclerosing cholangitis (PSC).
• Prolonged survival without transplantation in some PSC patients necessitates careful consideration of transplant indications.
• Understanding the efficacy and optimal timing of liver transplantation in PSC is crucial.

Purpose of the Study:

• To assess the long-term outcomes of liver transplantation in patients with primary sclerosing cholangitis (PSC).
• To compare patient survival after transplantation with expected survival based on prognostic models.
• To evaluate the impact of previous abdominal surgery and cancer development on outcomes.

Main Methods:

• A cohort of 51 patients with primary sclerosing cholangitis (PSC) undergoing various treatments, including liver transplantation, was analyzed.
• Long-term results of therapeutic interventions were assessed.
• Patient survival rates were compared to established prognostic models.

Main Results:

• Actuarial survival 5 years post-liver transplantation was 89%, significantly exceeding the 31% expected from prognostic models (p < 0.001).
• Nontransplantation biliary surgery yielded a 10-year symptom-free survival rate of 35%.
• Cancer incidence at 5 and 10 years post-PSC onset was 13% and 31%, respectively. Previous abdominal surgery increased in-hospital mortality (p < 0.05).

Conclusions:

• Liver transplantation demonstrably improves the prognosis for patients diagnosed with primary sclerosing cholangitis (PSC).
• Early liver transplantation is advised due to the potential for developing cancer and the risks associated with prior abdominal surgeries.
• Identifying patients who will benefit from non-transplant interventions remains a challenge, further supporting timely transplantation consideration.